NCT00427661View on ClinicalTrials.gov

A Pilot Study of HSCT for Patients With High-risk Hemoglobinopathy Using a Nonmyeloablative Preparative Regimen

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

June 30, 2002

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Sickle Cell DiseaseThalassemiaHemoglobinopathies
Interventions
OTHER

Busulfan; Fludarabine; cyclosporine A and MMF

Hematopoietic stem cell transplantation from a matched sibling or unrelated donor following a reduced intensity conditioning regimen

Trial Locations (1)

15213

Children's Hospital of Pittsburgh, Pittsburgh

All Listed Sponsors
lead

University of Pittsburgh

OTHER

NCT00427661 - A Pilot Study of HSCT for Patients With High-risk Hemoglobinopathy Using a Nonmyeloablative Preparative Regimen | Biotech Hunter | Biotech Hunter